No black box warning on record for Angiotensin Ii

As of the latest FDA labeling reviewed, Angiotensin Ii (ANGIOTENSIN II) does not carry a black box warning. Standard warnings and precautions still apply — see the full Angiotensin Ii medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • There is a potential for venous and arterial thrombotic and thromboembolic events in patients who receive Angiotensin II. Use concurrent venous thromboembolism (VTE) prophylaxis. ( 5.1 , 6.1 ) 5.1 Risk for Thrombosis The safety of Angiotensin II was evaluated in 321 adults with septic or other distributive shock in a randomized, double-blind, placebo-controlled study,

No black box warning on record for Angiotensin Ii

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • There is a potential for venous and arterial thrombotic and thromboembolic events in patients who receive Angiotensin II. Use concurrent venous thromboembolism (VTE) prophylaxis. ( 5.1 , 6.1 ) 5.1 Risk for Thrombosis The safety of Angiotensin II was evaluated in 321 adults with septic or other distributive shock in a randomized, double-blind, placebo-controlled study,

Angiotensin Ii Black Box Warning

No black box warning on record for Angiotensin Ii

Other warnings & precautions

Angiotensin Ii Black Box Warning

No black box warning on record for Angiotensin Ii

Other warnings & precautions